Published in Cancer Genet Cytogenet on November 01, 1995
Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study Group. Lancet (1998) 4.05
Complex of meningococcal group B polysaccharide and type 2 outer membrane protein immunogenic in man. J Clin Invest (1979) 3.61
Retinal damage by light in rats. Invest Ophthalmol (1966) 3.52
DNA microarrays identification of primary and secondary target genes regulated by p53. Oncogene (2001) 3.28
V(D)J recombination defects in lymphocytes due to RAG mutations: severe immunodeficiency with a spectrum of clinical presentations. Blood (2001) 2.50
Western equine encephalomyelitis vaccine produced in chick embryo cell cultures. Appl Microbiol (1966) 2.48
Diversity of germ-line immunoglobulin VH genes. Nature (1981) 2.47
Activation of a cellular oncogene by DNA rearrangement: possible involvement of an IS-like element. Nature (1982) 2.45
A possible role for CXCR4 and its ligand, the CXC chemokine stromal cell-derived factor-1, in the development of bone marrow metastases in neuroblastoma. J Immunol (2001) 2.33
Activation of the c-mos oncogene in a mouse plasmacytoma by insertion of an endogenous intracisternal A-particle genome. Proc Natl Acad Sci U S A (1983) 2.23
Differential mRNA stability to reticulocyte ribonucleases correlates with 3' non-coding (U)nA sequences. Eur J Biochem (1988) 2.19
Simple DNA sequences in homologous flanking regions near immunoglobulin VH genes: a role in gene interaction? Nucleic Acids Res (1982) 2.19
Organization and evolution of immunoglobulin VH gene subgroups. Proc Natl Acad Sci U S A (1982) 2.18
The effect of discharge pack formula and breast pumps on breastfeeding duration and choice of infant feeding method. Birth (1997) 2.08
Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning: the role of dose intensity. Leukemia (2006) 2.04
Therapy with thalidomide in refractory multiple myeloma patients - the revival of an old drug. Br J Haematol (2000) 2.02
Homology between an endogenous viral LTR and sequences inserted in an activated cellular oncogene. Nature (1983) 1.98
Prevention of shigellosis by a Salmonella typhi-Shigella sonnei bivalent vaccine. J Infect Dis (1987) 1.90
Gene expression profiling of parkinsonian substantia nigra pars compacta; alterations in ubiquitin-proteasome, heat shock protein, iron and oxidative stress regulated proteins, cell adhesion/cellular matrix and vesicle trafficking genes. J Neural Transm (Vienna) (2004) 1.89
Safety and immunogenicity of a Neisseria meningitidis type 2 protein vaccine in animals and humans. J Infect Dis (1978) 1.86
Rearrangements in the p53 gene in Philadelphia chromosome positive chronic myelogenous leukemia. Blood (1989) 1.85
Evolutionary aspects of immunoglobulin heavy chain variable region (VH) gene subgroups. Proc Natl Acad Sci U S A (1983) 1.72
Respiratory rate: measurement of variability over time and accuracy at different counting periods. Arch Dis Child (1991) 1.68
Rearrangement of the oncogene c-mos in mouse myeloma NSI and hybridomas. Nature (1984) 1.66
Carcinoid tumors frequently display genetic abnormalities involving chromosome 11. J Clin Endocrinol Metab (1996) 1.65
The CC2D1A, a member of a new gene family with C2 domains, is involved in autosomal recessive non-syndromic mental retardation. J Med Genet (2005) 1.65
Cerebral activation in patients with irritable bowel syndrome and control subjects during rectosigmoid stimulation. Psychosom Med (2001) 1.64
Evaluation of the appropriateness of blood and blood product transfusion using preset criteria. Transfusion (1989) 1.57
"Retroposon" insertion into the cellular oncogene c-myc in canine transmissible venereal tumor. Proc Natl Acad Sci U S A (1985) 1.56
Analysis of recombinant DNA clones specific for the murine p53 cellular tumor antigen. EMBO J (1983) 1.55
Genetic basis of hemolytic anemia caused by pyrimidine 5' nucleotidase deficiency. Blood (2001) 1.52
Nuclear membrane protein LAP2beta mediates transcriptional repression alone and together with its binding partner GCL (germ-cell-less). J Cell Sci (2001) 1.51
Genital Chlamydia infections in sexually active female adolescents: do we really need to screen everyone? J Adolesc Health (1997) 1.50
Alcohol use and pregnancy: improving identification. Obstet Gynecol (1998) 1.50
Evaluation of a new cephalosporin antibiotic, cephapirin. Antimicrob Agents Chemother (1972) 1.50
Gene expression profiles of AML derived stem cells; similarity to hematopoietic stem cells. Leukemia (2006) 1.50
Chromosomal translocation (1:13) in a case of alveolar rhabdomyosarcoma. J Pediatr Hematol Oncol (1998) 1.48
Neonates born to pre-eclamptic mothers have a higher percentage of natural killer cells (CD3-/CD56+16+) in umbilical cord blood than those without pre-eclampsia. J Matern Fetal Neonatal Med (2003) 1.44
Malignant osteopetrosis manifested as juvenile chronic myeloid leukemia. Pediatr Hematol Oncol (1993) 1.44
Rapid diagnosis of Chlamydia trachomatis pneumonia in infants by direct immunofluorescence microscopy of nasopharyngeal secretions. J Pediatr (1986) 1.43
Brief report: lymphoma with recurrent cycles of spontaneous remission and relapse--possible role of apoptosis. N Engl J Med (1995) 1.42
Infantile idiopathic thrombocytopenic purpura. Pediatr Hematol Oncol (1990) 1.42
Direct expenditures related to otitis media diagnoses: extrapolations from a pediatric medicaid cohort. Pediatrics (2000) 1.41
Severe hypophosphataemia in autograft recipients during accelerated leucocyte recovery. Br J Haematol (1995) 1.39
Recurrent bilateral parotitis in acute myeloid leukemia. Acta Haematol (1991) 1.39
Transient normal platelet counts and decreased requirement for interferon during pregnancy in essential thrombocythaemia. Br J Haematol (1996) 1.39
Chromosomal aberrations and gene expression profiles in non-small cell lung cancer. Lung Cancer (2007) 1.38
National Practitioner Data Bank highlights risk management meeting. QRB Qual Rev Bull (1989) 1.38
Substance abuse among patients presenting at an inner-city psychiatric emergency room. Hosp Community Psychiatry (1993) 1.38
DNA microarray analysis of genes involved in p53 mediated apoptosis: activation of Apaf-1. Oncogene (2001) 1.37
Quality of life in patients with human immunodeficiency virus infection: impact of social support, coping style and hopelessness. Int J STD AIDS (1999) 1.34
The characterization and localization of the mouse thymopoietin/lamina-associated polypeptide 2 gene and its alternatively spliced products. Genome Res (1996) 1.33
The CXCR4 antagonist AMD3100 impairs survival of human AML cells and induces their differentiation. Leukemia (2008) 1.33
Parallel induction of ATM-dependent pro- and antiapoptotic signals in response to ionizing radiation in murine lymphoid tissue. Oncogene (2006) 1.29
Neural expression and chromosomal mapping of Neu differentiation factor to 8p12-p21. Proc Natl Acad Sci U S A (1993) 1.28
Acute lower respiratory tract illnesses in Cali, Colombia: a two-year ambulatory study. Pediatrics (1983) 1.27
Brief intervention for alcohol use in pregnancy: a randomized trial. Addiction (1999) 1.27
Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children. Stroke (2000) 1.20
Immunization recall: effectiveness and barriers to success in an urban teaching clinic. J Pediatr (2001) 1.19
Rheumatic manifestations preceding adult acute leukemia: characteristics and implication in course and prognosis. Acta Haematol (1999) 1.18
Detection and quantitative evaluation of lupus circulating anticoagulant activity. Thromb Haemost (1987) 1.17
Polymorphism of germ-line immunoglobulin VH genes correlates with allotype and idiotype markers. Eur J Immunol (1981) 1.17
Maternal intravascular inflammation in preterm premature rupture of membranes. J Matern Fetal Neonatal Med (2002) 1.14
Common origin of transmissible venereal tumors (TVT) in dogs. Oncogene (1987) 1.13
Antimicrobial peptides in amniotic fluid: defensins, calprotectin and bacterial/permeability-increasing protein in patients with microbial invasion of the amniotic cavity, intra-amniotic inflammation, preterm labor and premature rupture of membranes. J Matern Fetal Neonatal Med (2003) 1.12
Is CT scan still necessary for staging in Hodgkin and non-Hodgkin lymphoma patients in the PET/CT era? Ann Oncol (2005) 1.12
A preventive, psychoeducational approach to increase perceived social support. Am J Community Psychol (1995) 1.12
Cancer cells suppress p53 in adjacent fibroblasts. Oncogene (2008) 1.10
Acute promyelocytic leukaemia with t(15;17) following treatment of Hodgkin's disease--a report of 4 cases. Ann Oncol (1995) 1.09
Drug-induced erythrocyte membrane internalization. J Clin Invest (1972) 1.08
Selective primary health care: strategies for control of disease in the developing world. XXI. Acute respiratory infections. Rev Infect Dis (1985) 1.07
High-throughput, sensitive and quantitative assay for the detection of BCR-ABL kinase domain mutations. Leukemia (2007) 1.06
Mechanism of activation of the mouse c-mos oncogene by the LTR of an intracisternal A-particle gene. EMBO J (1984) 1.06
Three-dimensional spectral precision distance microscopy of chromatin nanostructures after triple-colour DNA labelling: a study of the BCR region on chromosome 22 and the Philadelphia chromosome. J Microsc (2000) 1.06
A family with three beta-delta-thalassemia homozygotes. Blood (1970) 1.06
Preparation of purified suspensions of Coxiella burneti by Genetron extraction followed by continuous-flow ultracentrifugation. Appl Microbiol (1972) 1.06
The effect of the 5-HT3 receptor antagonist, alosetron, on brain responses to visceral stimulation in irritable bowel syndrome patients. Aliment Pharmacol Ther (2002) 1.05
Plasma glutathione peroxidase deficiency and platelet insensitivity to nitric oxide in children with familial stroke. Arterioscler Thromb Vasc Biol (1999) 1.04
Structural organization of the murine c-kit proto-oncogene. Oncogene (1992) 1.04
Evidence of in vivo generation of thrombin in patients with small-for-gestational-age fetuses and pre-eclampsia. J Matern Fetal Neonatal Med (2002) 1.04
Vincristine treatment triggering the expression of asymptomatic Charcot-Marie-Tooth disease. Med Pediatr Oncol (1996) 1.03
Identifying prenatal alcohol use: screening instruments versus clinical predictors. Am J Addict (1999) 1.03
Profile of gene expression regulated by induced p53: connection to the TGF-beta family. FEBS Lett (2000) 1.03
Is the molecular composition of K(ATP) channels more complex than originally thought? J Mol Cell Cardiol (2001) 1.03
Phenotypic and metabolic characteristics of monocytes and granulocytes in normal pregnancy and maternal infection. Am J Obstet Gynecol (2001) 1.03
Successful treatment of invasive aspergillosis in chronic granulomatous disease by granulocyte transfusions followed by peripheral blood stem cell transplantation. Bone Marrow Transplant (2000) 1.02
Age-dependent spatial memory loss can be partially restored by immune activation. Rejuvenation Res (2008) 1.02
Extramedullary disease and targeted therapies for hematological malignancies--is the association real? Ann Oncol (2006) 1.02
Amniotic fluid matrix metalloproteinase-8 in preterm labor with intact membranes. Am J Obstet Gynecol (2001) 1.02
Value of amniotic fluid neutrophil collagenase concentrations in preterm premature rupture of membranes. Am J Obstet Gynecol (2001) 1.02
Imatinib mesylate (STI571) in preparation for allogeneic hematopoietic stem cell transplantation and donor lymphocyte infusions in patients with Philadelphia-positive acute leukemias. Leukemia (2003) 1.01